The global weight reduction medicine market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The major driving factor for the growth of the weight reduction medicine market is unhealthy lifestyle and stress among population globally. People with busy lifestyles do not spare time to have a scheduled exercise routine each day. This is causing a negative impact on their body. Alcohol consumption has also proved to be a reason for an increase in weight. Pharmaceutical companies are including herbal plants and natural weight loss supplements to foster a safe, healthy weight loss regime in the consumers. Leading players who are operating in the weight reduction medicine market are adopting innovative marketing strategies to grow their sales in developing countries. People in developing countries are not aware of the weight reduction program, supplements, drugs that are prevailing in the market. Various fat-burning drugs are available in the market which are given in combination with a healthy diet and exercise. For instance, in May 2020, a fat-burning drug called PhenQ was introduced by Wolfson Berg Ltd. Drug maintains blood sugar levels in the human body and boosts energy. It contains the natural mineral chromium picolinate. It is seen in recent times that people are suffering from cardiac diseases, high blood pressure, hypertension, etc.
Browse the full report description of “Global Weight Reduction Medicine Market Size, Share & Trends Analysis Report By Product Type (Prescription And Over The Counter), By Application (Appetite Suppression, Fat Blocking, And Others), And By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies And Online Pharmacies) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/weight-reduction-medicine-market
A major reason for the rise in such health conditions is excessive weight gain in adults and teenagers. One in three adults in the US is suffering from obesity. Safe weight loss options should be made available in the market to overcome this problem. For instance, in March 2020, a weight-loss drug named Plenity was made available in the market. Gelesis, the company which produced this drug, said that this drug could only be used in adults with a body mass index of at least 25.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product
o By application
o By distribution channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Novo Nordisk, Glaxo smith kline, Vivus Pharmaceuticals, currax pharmaceuticals LLC, Pfizer Inc., and others
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How does COVID-19 impact the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global weight reduction medicine Market Report by Segment
By Product
By Application
By Distribution channel
Global weight reduction medicine Market Report byby Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/weight-reduction-medicine-market